Caitong International Asset Management Co., LTD Agios Pharmaceuticals, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 45 shares of AGIO stock, worth $1,506. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45
Previous 759
94.07%
Holding current value
$1,506
Previous $24.9 Million
94.72%
% of portfolio
0.0%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding AGIO
# of Institutions
237Shares Held
60.1MCall Options Held
323KPut Options Held
367K-
Farallon Capital Management LLC San Francisco, CA5.7MShares$191 Million0.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$188 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$163 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$118 Million2.39% of portfolio
-
State Street Corp Boston, MA2.45MShares$82 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.83B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...